Remove pharmaceutics research
article thumbnail

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

Pharmafile

Prism BioLab has announced that it has entered into a target-exclusive research and licensing agreement with Ono Pharmaceutical. Under the terms of this agreement, the two companies will collaboratively develop a candidate for Ono’s oncology target using Prism’s PepMetrics technology.

64
article thumbnail

Indian Institute based research boosting pharmaceutical industrial R&D and revenue

Pharma Tutor

Indian Institute based research boosting pharmaceutical industrial R&D and revenue admin Thu, 03/07/2024 - 14:23 Pharmaceutical research conducted by institutes plays a crucial role in boosting industrial research and development (R&D) in the pharmaceutical sector.

88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ono Pharmaceutical enters research deal with Monash University

Pharmaceutical Technology

Ono Pharmaceutical and Monash University have entered an option and research collaboration for the discovery and development of antibodies that target G protein-coupled receptors (GPCRs). We look forward to working with Ono Pharmaceutical to accelerate treatments across a variety of diseases.”.

52
article thumbnail

Pharmaceutical research in space

pharmaphorum

They discuss how research conducted in space can advance life sciences research, especially in oncology. On today’s podcast, host Jonah Comstock welcomes Christina Corridon, global lead of oncology at ZS Associates and Sandeep Sangwan, who leads the knowledge services R&D team at ZS.

52
article thumbnail

AI, Machine Learning Can Bring Significant Benefits to Pharmaceutical Development, Research

Pharmacy Times

Identifying the best uses for these tools, whether in patient education, data collection, improving efficiencies, or other uses, could significantly improve the future of pharmacy.

101
101
article thumbnail

MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases

Pharmafile

The collaboration will allow for the discovery, and potential development and commercialization of RNAa therapeutic candidates targeting a number of rare genetic diseases. read more

52
article thumbnail

BioMed X and Ono Pharmaceutical enter joint cancer research project

Pharma Times

The BioMed X Institute and Ono Pharmaceutical have announced a new joint research collaboration for cancer research. Hosted in Germany by the BioMed X Institute, the new research team will combine nine other research groups to uncover novel neutrophil biology and leverage their functions to design novel immunotherapies.